Three years of long-term monitoring MR condition labels ensure patient safety management Medtronic CareLink ™ network is compatible with remote monitoring
The Reveal ICM stands for Insertable Heart Monitor (ICM), records electrocardiograms, and helps medical staff make correct decisions about patients with suspected or known syncope and / or unknown or transient arrhythmias. Equipped with an algorithm for exclusive AF detection, the device is able to track patients facing transient symptoms that are signal of a cardiac arrhythmia. Due to the complexity of diagnosing and examining these patients, it is necessary to use technology options that provide clear information. Reveal ICM has been used to monitor ECGs for three years. With this fact in mind, it has been able to overcome the common limitations in most monitoring and testing options. Devices equipped with AF detection function can automatically classify rhythm types into asystole, bradyarrhythmias, fast ventricular tachyarrhythmia (FVT), ventricular tachyarrhythmia (VT) and atrial tachyarrhythmia/atrial fibrillation (AT/AF). The AF detection algorithm also helps detect the presence of AT / AF as well as asymptomatic attacks.
Specification
Volume: 9 cc Dimensions: 95 mm x 62 mm x 8 mm Weight: 15 g Distance between electrodes: 40 mm MRI compatibility: MR conditional at 1.5 and 3.0 T with 6 weeks of waiting period after insertion Battery longevity: Estimated 3 Years
Features
Three years of long-term monitoring MR condition labels ensure patient safety management Medtronic CareLink ™ network is compatible with remote monitoring Atrial Arrhythmia / Atrial Fibrillation (AT / AF) Ventricular Arrhythmia (VT) Fast ventricular tachyarrhythmia (FVT) Bradycardia Cardiac arrest May detect the presence of AT / AF, including asymptomatic attacks Monitor AT / AF burden to assess if treatment is needed or treatment should be adjusted Monitor ventricular rhythm during atrial arrhythmias to evaluate the efficacy of rate control therapy Easy access to diagnostic data without office visits-optimize planning and treatment Data can be sent immediately after the patient's marker event or at scheduled intervals Reveal Vector Check determines optimal implant position Reveal XT ICM is placed under the skin above the chest Slim, lead-free device simplifies insertion